Stock Analysts’ Price Target Changes for June 18th (CWB, EMP.A, GFL, NA, PRMW, RCH, WEED, ZNTL)

Stock Analysts’ price target changes for Tuesday, June 18th:

Canadian Western Bank (TSE:CWB) had its target price boosted by Desjardins from C$32.00 to C$52.00. They currently have a buy rating on the stock.

Canadian Western Bank (TSE:CWB) had its price target boosted by Scotiabank from C$30.00 to C$52.00. They currently have an outperform rating on the stock.

Empire (TSE:EMP.A) was given a C$38.00 target price by analysts at Desjardins. The firm currently has a buy rating on the stock.

GFL ENVIRON-TS (CVE:GFL) was given a C$66.00 price target by analysts at ATB Capital. The firm currently has an outperform rating on the stock.

GFL ENVIRON-TS (CVE:GFL) had its price target increased by Stifel Nicolaus from C$60.00 to C$70.00. They currently have a buy rating on the stock.

National Bank of Canada (TSE:NA) had its price target lowered by BMO Capital Markets from C$121.00 to C$115.00. The firm currently has an outperform rating on the stock.

National Bank of Canada (TSE:NA) had its target price lowered by Scotiabank from C$119.00 to C$116.00. The firm currently has a hold rating on the stock.

Primo Water (NYSE:PRMW) had its price target raised by TD Securities from $30.00 to $32.00. They currently have a buy rating on the stock.

Richelieu Hardware (TSE:RCH) was given a C$45.50 price target by analysts at National Bankshares, Inc.. The firm currently has a sector perform rating on the stock.

Canopy Growth (TSE:WEED) was given a C$10.00 target price by analysts at ATB Capital. The firm currently has a sector perform rating on the stock.

Zentalis Pharmaceuticals (NASDAQ:ZNTL) had its target price reduced by Stifel Nicolaus from $32.00 to $10.00. The firm currently has a buy rating on the stock.

Zentalis Pharmaceuticals (NASDAQ:ZNTL) had its price target reduced by HC Wainwright from $40.00 to $20.00. They currently have a buy rating on the stock.

Zentalis Pharmaceuticals (NASDAQ:ZNTL) had its target price trimmed by Oppenheimer Holdings Inc. from $50.00 to $25.00. They currently have an outperform rating on the stock.